ey0017.12-5 | Type 2 Diabetes | ESPEYB17
WV Tamborlane
, M Barrientos-Perez
, U, et al. Fainberg
To read the full abstract: N Engl J Med. 2019;381(7):63746. doi: 10.1056/NEJMoa1903822Short summary: Liraglutide is superior to placebo in improving glycaemic control in children and adolescents with T2DM.Comment: Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, also known as an incretin mimetic. It causes glucose-dependent sti...